Last reviewed · How we verify
NCT03510949
Nasopharyngeal Versus Laryngeal Mask Airway in Anaesthesia for Bilateral Blepharoplasty
NA trial testing Nasopharyngeal airway or laryngeal mask airway in Injury Throat in 148 participants. Completed in 1 July 2018.
1 July 2018
Quick facts
| Lead sponsor | Hala Salah El-Din El-Ozairy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 148 |
| Start date | 1 February 2018 |
| Primary completion | 1 July 2018 |
| Estimated completion | 1 July 2018 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Nasopharyngeal airway or laryngeal mask airway
Conditions studied
- Injury Throat — all drugs for Injury Throat →
Sponsor
Hala Salah El-Din El-Ozairy
Who can join
Adults 40 to 60, any sex, with Injury Throat. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
General anaesthesia demands securing patient's airway either with endotracheal tube or laryngeal mask (LMA); however, both carry the disadvantage of postoperative soar throat. Nasopharyngeal airway (NPA) can be an alternative without the risk of postoperative soar throat.6 The primary end point of our study is to assess the incidence of soar throat with the use of NPA compared to LMA in patients receiving general anaesthesia during blepharoplasty.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison between nasopharyngeal airway and laryngeal mask airway in blepharoplasty under general anaesthesia. A randomized controlled trial.
El-Ozairy HSE, Abd-Elmaksoud AM, El-Hennawy AM. · · 2020 · cited 4× · PMID 33327697 · DOI 10.5114/ait.2020.101412
Verify or expand the search:
- PubMed search for NCT03510949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03510949 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hala Salah El-Din El-Ozairy
- Last refreshed: 3 July 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03510949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing